Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma.
Mairinger E, Wessolly M, Buderath P, Borchert S, Henrich L, Mach P, Steinborn J, Kimming R, Jasani B, Schmid KW, Bankfalvi A, Mairinger FD. Mairinger E, et al. Among authors: schmid kw. Front Oncol. 2023 Nov 8;13:1252700. doi: 10.3389/fonc.2023.1252700. eCollection 2023. Front Oncol. 2023. PMID: 38023247 Free PMC article.
Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target.
Greimelmaier K, Klopp N, Mairinger E, Wessolly M, Borchert S, Steinborn J, Schmid KW, Wohlschlaeger J, Mairinger FD. Greimelmaier K, et al. Among authors: schmid kw. Pathol Oncol Res. 2023 Aug 8;29:1611163. doi: 10.3389/pore.2023.1611163. eCollection 2023. Pathol Oncol Res. 2023. PMID: 37614665 Free PMC article.
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting.
Kraskowski O, Stratmann JA, Wiesweg M, Eberhardt W, Metzenmacher M, Schmid KW, Herold T, Schildhaus HU, Darwiche K, Aigner C, Stuschke M, Laue K, Zaun G, Kasper S, Hense J, Sebastian M, Schuler M, Pogorzelski M. Kraskowski O, et al. Among authors: schmid kw. J Cancer Res Clin Oncol. 2023 Sep;149(11):9243-9252. doi: 10.1007/s00432-023-04839-3. Epub 2023 May 18. J Cancer Res Clin Oncol. 2023. PMID: 37198447 Free PMC article.
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.
Maßmann M, Treckmann J, Markus P, Schumacher B, Albers D, Ting S, Mende B, Roehrle J, Virchow I, Rosery V, Laue K, Zaun G, Kostbade K, Pogorzelski M, Schmid KW, Baba H, Siveke JT, Paul A, Schildhaus HU, Schuler M, Wiesweg M, Kasper S. Maßmann M, et al. Among authors: schmid kw. J Cancer Res Clin Oncol. 2023 Jul;149(8):5085-5094. doi: 10.1007/s00432-022-04424-0. Epub 2022 Nov 5. J Cancer Res Clin Oncol. 2023. PMID: 36334155 Free PMC article.
[Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].
Dralle H, Weber F, Machens A, Brandenburg T, Schmid KW, Führer-Sakel D. Dralle H, et al. Among authors: schmid kw. Chirurgie (Heidelb). 2023 Jan;94(1):79-92. doi: 10.1007/s00104-022-01726-4. Epub 2022 Sep 19. Chirurgie (Heidelb). 2023. PMID: 36121448 Review. German.
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Rosery V, Mika S, Schmid KW, Reis H, Stuschke M, Treckmann J, Markus P, Schumacher B, Albers D, Mende B, Lahner H, Wiesweg M, Schuler M, Siveke JT, Kasper S. Rosery V, et al. Among authors: schmid kw. J Cancer Res Clin Oncol. 2023 Jul;149(8):4315-4325. doi: 10.1007/s00432-022-04314-5. Epub 2022 Sep 8. J Cancer Res Clin Oncol. 2023. PMID: 36071236 Free PMC article.
Multimodal survival prediction in advanced pancreatic cancer using machine learning.
Keyl J, Kasper S, Wiesweg M, Götze J, Schönrock M, Sinn M, Berger A, Nasca E, Kostbade K, Schumacher B, Markus P, Albers D, Treckmann J, Schmid KW, Schildhaus HU, Siveke JT, Schuler M, Kleesiek J. Keyl J, et al. Among authors: schmid kw. ESMO Open. 2022 Oct;7(5):100555. doi: 10.1016/j.esmoop.2022.100555. Epub 2022 Aug 18. ESMO Open. 2022. PMID: 35988455 Free PMC article.
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
Erber R, Angeloni M, Stöhr R, Lux MP, Ulbrich-Gebauer D, Pelz E, Bankfalvi A, Schmid KW, Walter RFH, Vetter M, Thomssen C, Mayr D, Klauschen F, Sinn P, Sotlar K, Stering K, Stenzinger A, Wunderle M, Fasching PA, Beckmann MW, Hoffmann O, Kimmig R, Harbeck N, Wuerstlein R, Ferrazzi F, Hartmann A. Erber R, et al. Among authors: schmid kw. Int J Mol Sci. 2022 Aug 5;23(15):8716. doi: 10.3390/ijms23158716. Int J Mol Sci. 2022. PMID: 35955851 Free PMC article.
568 results